IN FOCUS

2.5 million doses Covid-19 vaccine start being rolled out in Pakistan

2.5 million doses of Moderna COVID-19 vaccines supplied through the COVAX mechanism, and donated by the US, started being distributed by Pakistan to vaccinate priority groups across the country.

Today 2.5 million doses of Moderna (mRNA-1273) COVID-19 vaccines supplied through the COVAX Facility‘s dose-sharing mechanism, and donated by the United States, started being distributed by the Government of Pakistan to vaccinate priority groups across the country, in line with the National Deployment and Vaccination Plan.

So far three million people have been fully vaccinated and 13.5 million partially vaccinated in Pakistan, using vaccines which the Government procured through COVAX or through bilateral agreements. More than 960,000 cases of COVID-19 have been reported in the country since the start of the outbreak and at least 22,379 people have succumbed to the disease.

“WHO applauds Pakistan’s achievement of effectively scaling-up its vaccination campaign across the country. The available  vaccines have been equitably distributed and have reached even the remotest areas of Pakistan, protecting millions. Science, solutions and solidarity have been the tools for addressing the biggest health threat of the past century. We thank the Government of United States for showing their solidarity through this donation,” said Dr Palitha Mahipala, WHO Representative in Pakistan. “WHO will continue supporting the Government of Pakistan to swiftly and safely administer the donated doses of vaccines and advocate with COVAX partners for the provision of sufficient vaccines to reach all vulnerable populations.”

The arrival of this consignment is welcome news as the latest wave of COVID-19 has had a devastating impact on children and their families in South Asia. There is an urgent need to intensify efforts and take additional steps to close gaps and strengthen essential health services to protect the most vulnerable families.

In the spirit of solidarity, well-supplied countries are allocating extra doses of COVID-19 vaccines for low- and middle- income countries. This can help limit the spread of COVID-19, prevent new variants from emerging and ensure that vaccines can be allocated equitably to countries.

Source: WHO

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button